Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
alpha-D-glucose 1-phosphate + UDP-alpha-D-galactose
UDP-alpha-D-glucose + alpha-D-galactose 1-phosphate
-
-
-
r
UDP-alpha-D-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-alpha-D-galactose
-
-
-
r
UDP-alpha-D-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-alpha-D-galactose
-
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
UDP-glucose + D-galactose 1-phosphate
D-glucose 1-phosphate + UDP-galactose
-
-
-
-
?
UTP + alpha-D-galactose 1-phosphate
diphosphate + UDP-alpha-D-galactose
-
-
-
-
?
additional information
?
-
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
2-step mechanism
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
galactosemia with altered activity of the follicle-stimulating hormone FSH
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
important step in galactose metabolism
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
-
?
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
2nd step of Leloir pathway
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
2nd step of Leloir pathway
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
involved in the biosynthesis of follicle-stimulating hormone FSH
-
r
additional information
?
-
-
-
-
-
?
additional information
?
-
-
inverse relationship between enzyme activity and galactose sensitivity
-
-
?
additional information
?
-
-
the enzyme has a strict requirement for UDP-glucose or UDP-galactose as substrates, while GDP-glucose, ADP-glucose, TDP-glucose, CDP-glucose, UDPxylose, and UDP-mannose are all unable to support activity
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UDP-alpha-D-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-alpha-D-galactose
-
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
UTP + alpha-D-galactose 1-phosphate
diphosphate + UDP-alpha-D-galactose
-
-
-
-
?
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
galactosemia with altered activity of the follicle-stimulating hormone FSH
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
important step in galactose metabolism
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
-
?
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
essential enzyme in galactose metabolism, deficiency causes genetic disorder galactosemia, e.g. mutant Duarte variant
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
2nd step of Leloir pathway
-
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
2nd step of Leloir pathway
-
r
UDP-glucose + alpha-D-galactose 1-phosphate
alpha-D-glucose 1-phosphate + UDP-galactose
-
involved in the biosynthesis of follicle-stimulating hormone FSH
-
r
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Carcinoma, Ovarian Epithelial
Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States).
Cataract
Association of presenile cataract with galactose-1-phosphate uridyl transferase gene mutations.
Cataract
Clinical features of galactokinase deficiency: a review of the literature.
Cataract
Negative screening tests in classical galactosaemia caused by S135L homozygosity.
Cataract
[Activity of enzymes of galactose metabolism in so-called congenital cataract (author's transl)]
Congenital Disorders of Glycosylation
Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
Craniosynostoses
A Novel Large Deletion Encompassing the Whole of the Galactose-1-Phosphate Uridyltransferase (GALT) Gene and Extending into the Adjacent Interleukin 11 Receptor Alpha (IL11RA) Gene Causes Classic Galactosemia Associated with Additional Phenotypic Abnormalities.
Endometriosis
Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis.
Fanconi Syndrome
Defective galactose oxidation in a patient with glycogen storage disease and Fanconi syndrome.
galactokinase deficiency
Biokinetics of galactose in the homozygotes and heterozygotes of both forms of galactosemia.
galactokinase deficiency
Clinical features of galactokinase deficiency: a review of the literature.
galactokinase deficiency
Hemoglobin A1 in galactosemia, a possible role in monitoring dietary compliance.
galactokinase deficiency
Recommendations for newborn screening for galactokinase deficiency: A systematic review and evaluation of Dutch newborn screening data.
galactokinase deficiency
Simultaneous quantitative estimation of galactose-1-phosphate and galactose in blood for the diagnosis of galactosemia.
Galactosemias
A Case of Classical Galactosemia: Identification and Characterization of 3 Distinct Mutations in Galactose-1-Phosphate Uridyl Transferase (GALT) Gene in a Single Family.
Galactosemias
A De Novo Variant in Galactose-1-P Uridylyltransferase (GALT) Leading to Classic Galactosemia.
Galactosemias
A Novel Large Deletion Encompassing the Whole of the Galactose-1-Phosphate Uridyltransferase (GALT) Gene and Extending into the Adjacent Interleukin 11 Receptor Alpha (IL11RA) Gene Causes Classic Galactosemia Associated with Additional Phenotypic Abnormalities.
Galactosemias
Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.
Galactosemias
An extensive computational approach to analyze and characterize the functional mutations in the galactose-1-phosphate uridyl transferase (GALT) protein responsible for classical galactosemia.
Galactosemias
Analysis of common mutations in the galactose-1-phosphate uridyl transferase gene: new assays to increase the sensitivity and specificity of newborn screening for galactosemia.
Galactosemias
Assessment of galactose-1-phosphate uridyltransferase activity in cells and tissues.
Galactosemias
Biokinetics of galactose in the homozygotes and heterozygotes of both forms of galactosemia.
Galactosemias
Clinical features of galactokinase deficiency: a review of the literature.
Galactosemias
Clinical significance of plasma galactose and erythrocyte galactose-1-phosphate measurements in transferase-deficient galactosemia and in individuals with below-normal transferase activity.
Galactosemias
Diagnosis of inherited disorders of galactose metabolism.
Galactosemias
Duarte (DG) galactosemia: a pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screening.
Galactosemias
Galactosemia: when is it a newborn screening emergency?
Galactosemias
GALT Deficiency Galactosemia.
Galactosemias
Hemoglobin A1 in galactosemia, a possible role in monitoring dietary compliance.
Galactosemias
Hereditary Galactosemia.
Galactosemias
Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age.
Galactosemias
Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.
Galactosemias
In vivo metabolism and UTP-depleting action of 2-deoxy-2-fluoro-D-galactose.
Galactosemias
Isoelectrofocusing of erythrocyte galactose 1 phospho uridyl transferase in a family with both galactosemia and Duarte variants.
Galactosemias
Issues on universal screening for galactosemia.
Galactosemias
Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.
Galactosemias
Neonatal screening for galactosemia by quantitative analysis of hexose monophosphates using tandem mass spectrometry: a retrospective study.
Galactosemias
Prenatal diagnosis of galactosemia and properties of galactose-1-phosphate uridyltransferase in erythrocytes of galactosemic variants as well as in human fetal and adult organs.
Galactosemias
Prenatal diagnosis of galactosemia.
Galactosemias
Problems in the diagnosis of transferase and galactokinase deficient galactosemia.
Galactosemias
Quantification of galactose-1-phosphate uridyltransferase enzyme activity by liquid chromatography-tandem mass spectrometry.
Galactosemias
Recommendations for newborn screening for galactokinase deficiency: A systematic review and evaluation of Dutch newborn screening data.
Galactosemias
Reversal of aberrant PI3K/Akt signaling by Salubrinal in a GalT-deficient mouse model.
Galactosemias
Simultaneous quantitative estimation of galactose-1-phosphate and galactose in blood for the diagnosis of galactosemia.
Galactosemias
The ability of an LC-MS/MS-based erythrocyte GALT enzyme assay to predict the phenotype in subjects with GALT deficiency.
Galactosemias
The adult galactosemic phenotype.
Galactosemias
The molecular relationship between deficient UDP-galactose uridyl transferase (GALT) and ceramide galactosyltransferase (CGT) enzyme function: a possible cause for poor long-term prognosis in classic galactosemia.
Galactosemias
Unusual presentation of galactosemia in a 4-month-old child.
Galactosemias
[A case of atypical galactosemia(author's transl)]
Galactosemias
[Association of thrombopenia due to platelet alloimmunization with galactosemia in the neonatal period]
Galactosemias
[Effectiveness of the screening programme for galactosemia. New strategy in Poland]
Galactosemias
[Efficacy of dietetic treatment in a case of galactosemia diagnosed late]
Galactosemias
[Late neurologic complications of galactosemia: study of 3 cases]
Genetic Diseases, Inborn
Assessment of galactose-1-phosphate uridyltransferase activity in cells and tissues.
Genetic Diseases, Inborn
Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.
Hepatomegaly
Negative screening tests in classical galactosaemia caused by S135L homozygosity.
Neoplasms
Mouse monoclonal antibodies which recognize a human (beta 1-4)galactosyl-transferase associated with tumor in body fluids.
Ovarian Neoplasms
Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis.
Primary Ovarian Insufficiency
Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age.
Pseudotumor Cerebri
Clinical features of galactokinase deficiency: a review of the literature.
Pyuria
Hemolysis due to Alpha-Hemolytic Enterococcus Urinary Infection: A Rare Cause of Early and Severe Unconjugated Hyperbilirubinemia in a Neonate.
Sepsis
Galactosemia: when is it a newborn screening emergency?
Tuberculosis
Identification of amino acids involved in catalytic process of M. tuberculosis GlmU acetyltransferase.
Tuberculosis
Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils.
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
Diagnosis and management of galactosemia: an Egyptian experience.
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
Duarte (DG) galactosemia: a pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screening.
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
Functional analysis of GALT variants found in classic galactosemia patients using a novel cell-free translation method.
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
Galactose-1 phosphate uridyl transferase deficiency in the western grey kangaroo (Macropus fuliginosus; marsupialia): a model system for gene therapy studies.
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
GALT Deficiency Galactosemia.
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
Hemoglobin A1 in galactosemia, a possible role in monitoring dietary compliance.
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
Molecular analysis of GALT gene in Argentinian population: Correlation with enzyme activity and characterization of a novel Duarte-like allele.
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
[Efficacy of dietetic treatment in a case of galactosemia diagnosed late]
udp-glucose-hexose-1-phosphate uridylyltransferase deficiency
[The frequency of uridyl transferase deficiency in patients with galactose intolerance]
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0459 - 1.184
alpha-D-galactose 1-phosphate
0.118 - 0.202
alpha-D-glucose 1-phosphate
0.0897 - 0.324
UDP-alpha-D-galactose
0.0608 - 0.4487
UDP-alpha-D-glucose
0.011 - 0.64
alpha-D-galactose 1-phosphate
additional information
additional information
-
0.0459
alpha-D-galactose 1-phosphate
mutant F194L, pH 8.8, 37°C
0.288
alpha-D-galactose 1-phosphate
mutant D28Y, pH 8.8, 37°C
0.29
alpha-D-galactose 1-phosphate
wild-type, pH 8.8, 37°C
1.184
alpha-D-galactose 1-phosphate
mutant R333G, pH 8.8, 37°C
0.118
alpha-D-glucose 1-phosphate
mutant F194L, pH 8.8, 37°C
0.121
alpha-D-glucose 1-phosphate
mutant D28Y, pH 8.8, 37°C
0.159
alpha-D-glucose 1-phosphate
wild-type, pH 8.8, 37°C
0.202
alpha-D-glucose 1-phosphate
mutant R333G, pH 8.8, 37°C
0.0897
UDP-alpha-D-galactose
mutant F194L, pH 8.8, 37°C
0.141
UDP-alpha-D-galactose
wild-type, pH 8.8, 37°C
0.179
UDP-alpha-D-galactose
mutant D28Y, pH 8.8, 37°C
0.324
UDP-alpha-D-galactose
mutant R333G, pH 8.8, 37°C
0.0608
UDP-alpha-D-glucose
mutant F194L, pH 8.8, 37°C
0.0816
UDP-alpha-D-glucose
wild-type, pH 8.8, 37°C
0.2857
UDP-alpha-D-glucose
mutant R333G, pH 8.8, 37°C
0.4487
UDP-alpha-D-glucose
mutant D28Y, pH 8.8, 37°C
0.011
alpha-D-galactose 1-phosphate
-
with UDP-glucose
0.021
alpha-D-galactose 1-phosphate
-
erythrocytes
0.09
alpha-D-galactose 1-phosphate
-
galactose grown cells, pH 8.2
0.09
alpha-D-galactose 1-phosphate
-
recombinant mutants P185E, pH 8.7, 37°C
0.1
alpha-D-galactose 1-phosphate
-
glucose grown cells, pH 8.2
0.15
alpha-D-galactose 1-phosphate
-
recombinant mutants P185Q, pH 8.7, 37°C
0.2
alpha-D-galactose 1-phosphate
-
pH 8.6, 37°C
0.2
alpha-D-galactose 1-phosphate
-
recombinant mutants P185G, pH 8.7, 37°C
0.31
alpha-D-galactose 1-phosphate
-
recombinant mutants P185S, pH 8.7, 37°C
0.42
alpha-D-galactose 1-phosphate
-
recombinant mutants P185A, pH 8.7, 37°C
0.57
alpha-D-galactose 1-phosphate
-
recombinant wild-type, pH 8.7, 37°C
0.57
alpha-D-galactose 1-phosphate
-
recombinant wild-type, pH 8.7, 42-48°C
0.64
alpha-D-galactose 1-phosphate
-
recombinant mutant S135L, pH 8.7, 42-48°C
0.015
UDP-glucose
-
erythrocytes
0.065
UDP-glucose
-
pH 8.6, 37°C
0.12
UDP-glucose
-
recombinant mutant S135L, pH 8.7, 42-48°C
0.13
UDP-glucose
-
wild-type from lymphoblasts, 37°C
0.14
UDP-glucose
-
recombinant mutant P185S, pH 8.7, 37°C
0.14
UDP-glucose
-
N314D homozygous mutant from lymphoblasts, 37°C
0.2
UDP-glucose
-
wild-type from erythrocytes, 37°C
0.2
UDP-glucose
-
recombinant wild-type and mutants P185E and P185A, pH 8.7, 37°C
0.21
UDP-glucose
-
recombinant wild-type, pH 8.7, 42-48°C
0.34
UDP-glucose
-
recombinant mutants P185G, pH 8.7, 37°C
0.4
UDP-glucose
-
recombinant mutants P185Q, pH 8.7, 37°C
additional information
additional information
-
-
-
additional information
additional information
-
kinetics
-
additional information
additional information
-
kinetics
-
additional information
additional information
-
kinetics
-
additional information
additional information
-
kinetics
-
additional information
additional information
-
wild-type and mutants in the 2-step reaction
-
additional information
additional information
-
wild-type and mutants in the 2-step reaction
-
additional information
additional information
-
steady-state kinetics of G, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A101D
mutation identified in a in patient with classic galactosemia
A276N
mutation identified in a in patient with classic galactosemia
D28Y
variant associated with type I galactosemia. 13.5% of wild-type activity
F171S
variant associated with type I galactosemia, residue is strictly conserved across species. No residual activity
F194L
variant associated with type I galactosemia. 11.9% of wild-type activity
L74P
variant associated with type I galactosemia, residue is strictly conserved across species. No residual activity
P257T
mutation identified in a in patient with classic galactosemia
Q188P
variant identified in a patient with classic galactosemia, introduces a missense substitution near the active site of the GALT enzyme. The variant is found in the compound heterozygous state in a child with classic galactosemia, but not in either of her parents. The patient inherited a common Q188R GALT mutation from the mother
R333G
variant associated with type I galactosemia, residue is strictly conserved across species. 0.6% of wild.type activtiy
Y165H
mutation identified in a in patient with classic galactosemia
E203K
-
native heterozygous mutant, reduced activity by about 50% in erythrocytes
E291K
-
site-directed mutagenesis for construction of the naturally occuring mutation, 62.8% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
E340X/L218L/N314D
-
native mutant, no or nearly no enzyme activity, L218L is a silent mutation, galactosemia phenotype
F171L
-
site-directed mutagenesis, 10fold decreased activity
F171W
-
site-directed mutagenesis, severely reduced abundance
F171Y
-
site-directed mutagenesis, 4% activity compared to wild-type, no inhibition by excess UDP-glucose
K285N
-
site-directed mutagenesis for construction of the naturally occuring mutation, below 0.2% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
L139P
-
site-directed mutagenesis for construction of the naturally occuring mutation, 1.9% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
L218L/N314D
-
native Duarte-1 D1 variant, L218L is a silent mutation, N314D leads to 110-130% activity compared to the wild-type
N314D/E203K
-
homozygous N314D mutant with introduced cis mutation E203K does no longer show the reduced, but the full activity and increased thermolablity of mutant without E203K
P183T
-
site-directed mutagenesis for construction of the naturally occuring mutation, 45.2% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
P185A
-
site-directed mutagenesis, reduced activity and reduced expression level compared to wild-type
P185C
-
site-directed mutagenesis, no remaining activity, same expression level compared to wild-type
P185D
-
site-directed mutagenesis, no remaining activity, same expression level compared to wild-type
P185E
-
site-directed mutagenesis, reduced activity, same expression level compared to wild-type
P185F
-
site-directed mutagenesis, no remaining activity, highly reduced expression level compared to wild-type
P185G
-
site-directed mutagenesis, reduced activity and expression level compared to wild-type
P185H
-
site-directed mutagenesis, no remaining activity, reduced expression level compared to wild-type
P185I
-
site-directed mutagenesis, no remaining activity, highly reduced expression level compared to wild-type
P185K
-
site-directed mutagenesis, no remaining activity, reduced expression level compared to wild-type
P185L
-
site-directed mutagenesis, no remaining activity, highly reduced expression level compared to wild-type
P185M
-
site-directed mutagenesis, no remaining activity, reduced expression level compared to wild-type
P185N
-
site-directed mutagenesis, no remaining activity, reduced expression level compared to wild-type
P185Q
-
site-directed mutagenesis, reduced activity, increased expression level compared to wild-type
P185R
-
site-directed mutagenesis, no remaining activity, same expression level compared to wild-type
P185S
-
site-directed mutagenesis, reduced activity, reduced expression level compared to wild-type
P185T
-
site-directed mutagenesis, no remaining activity, reduced expression level compared to wild-type
P185V
-
site-directed mutagenesis, no remaining activity, highly reduced expression level compared to wild-type
P185W
-
site-directed mutagenesis, no remaining activity, highly reduced expression level compared to wild-type
P185Y
-
site-directed mutagenesis, no remaining activity, reduced expression level compared to wild-type
Q188N
-
site-directed mutagenesis, reduced activity
R201H
-
site-directed mutagenesis for construction of the naturally occuring mutation, 62.8% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
R231H
-
site-directed mutagenesis for construction of the naturally occuring mutation, below 0.2% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
R258C
-
native mutant, 15-20% activity compared to wild-type, some clinical symptoms
R259W
-
site-directed mutagenesis for construction of the naturally occuring mutation, below 0.2% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
R333G
-
native mutant, 20% activity compared to wild-type, no clinical symptoms
R67C
-
site-directed mutagenesis for construction of the naturally occuring mutation, 2.3% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
T350A
-
site-directed mutagenesis for construction of the naturally occuring mutation, 9.9% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
V151A
-
site-directed mutagenesis for construction of the naturally occuring mutation, 4.6% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucosey
W316X/N314D/G1105C/G1391A
-
native mutant, nearly no enzyme activity, galactosemia phenotype
Y323D
-
site-directed mutagenesis for construction of the naturally occuring mutation, 9.6% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
K285N
naturally occuring mutation
K285N
the most common mutations, include p.S135L, p.N314D, p.Q188R, and p.K285N from different ethnicities. Computational pipeline is used to explore the crystal structure and effects due to the most prevalent mutations in the GALT protein. The mutation p.K285N is located in the alpha helix region (alpha4) of the protein is less pathogenic
K285N
the p.K285N allele shows a high frequency in Caucasians and is associated to null blood GALT activity and a severe clinical phenotype
N314D
naturally occuring mutation
N314D
the most common mutations, include p.S135L, p.N314D, p.Q188R, and p.K285N from different ethnicities. Computational pipeline is used to explore the crystal structure and effects due to the most prevalent mutations in the GALT protein. p.N314D mutation, located in the loop region is less pathogenic
Q188R
higher tendency of hGALT(p.Q188R) to aggregate due to its reduced ability to be uridylylated
Q188R
significant deviation and fluctuation in the p.Q188R mutation with a loss in compactness reduced the amount of intramolecular hydrogen bonds. p.Q188R mutation (located in the beta-sheet eight region) is extremely pathogenic and has destabilizing effects compared to the native and the other mutations
Q188R
the p.Q188R allele shows a high frequency in Caucasians and is associated to null blood GALT activity and a severe clinical phenotype
S135L
the mutant demonstrates reduced compactness and increased intramolecular hydrogen bonds. p.S135L mutation (located at the loop region) is extremely pathogenic and has destabilizing effects compared to the native and the other mutations
S135L
the substitution p.S135L is common in Africans and is associated to a mild phenotype albeit having less than 1% residual enzymatic GALT activity
F171S
-
site-directed mutagenesis, no activity
F171S
-
site-directed mutagenesis for construction of the naturally occuring mutation, below 0.2% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
N314D
-
site-directed mutagenesis for construction of the naturally occuring mutation, unaltered activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
N314D
-
native missense mutant Duarte D, homozygous, characteristic isoform, partial impairment of enzyme activity in human erythrocytes, fibroblasts, and transformed lymphoblasts, reduced Vmax, increased thermal lability
N314D/G1105C/G1391A
-
native Duarte-2 D2 variant, 40-50% activity compared to the wild-type
N314D/G1105C/G1391A
-
native Duarte-2 D2 variant with additional exchange of bases at 1323 G to A, 20-25% activity compared to wild-type, no clinical symptoms
Q188R
-
site-directed mutagenesis for construction of the naturally occuring mutation, below 0.2% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
Q188R
-
20-30% activity of wild-type activity as heterodimer with wild-type subunit, no activity as homodimer
Q188R
-
most common native mutation causing galactosemia in the white population
Q188R
-
site-directed mutagenesis for expression of the mutant in Escherichia coli, nearly no activity in vitro
Q188R
-
native mutant, no enzyme activity in vivo, galactosemia phenotype
R333W
-
site-directed mutagenesis for construction of the naturally occuring mutation, below 0.2% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
R333W
-
native mutant, catalytically inactive, galactosemic phenotype
R333W
-
20-30% activity of wild-type activity as heterodimer with wild-type subunit, no activity as homodimer
S135L
-
site-directed mutagenesis for construction of the naturally occuring mutation, 2.7% of wild-type activity, accumulation of alpha-D-galactose 1-phosphate, UDP-galactose and UDP-glucose
S135L
-
native mutant, can be found in about 50% of galactosemia patients of African-American descent, 10fold reduced enzyme activity compared to wild-type, no steric or electrochemical changes sufficiently close to the active site to result in partial impairment of the reaction
additional information
characterization of a large deletion spanning 8489 bp in the GALT gene accounting for the majority of disease alleles in Cypriot patients with classic galactosemia
additional information
-
characterization of a large deletion spanning 8489 bp in the GALT gene accounting for the majority of disease alleles in Cypriot patients with classic galactosemia
additional information
-
-
additional information
-
coexpression of wild-type and/or mutant subunits in yeast, study of dimer formation pattern and subunit assortment, mutations: S135L, F171S, F171W, H186G, Q188R, N314D, R333W, overview
additional information
-
Munich2 mutant with base exchange at 2252 G to T, 20-25% activity compared to wild-type, no clinical symptoms
additional information
-
native Schönstadt mutant with base exchange at 897 G to C, 15-20% activity compared to wild-type, some clinical symptoms
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Mayes, J.S.; Hansen, R.G.
Galactose 1-phosphate uridyl transferase
Methods Enzymol.
9
708-713
1966
Bos taurus, Homo sapiens
-
brenda
Helmer, G.R.; Williams, V.P.
Purification of galactose-1-phosphate uridylyltransferase from human placenta
Arch. Biochem. Biophys.
210
573-580
1981
Homo sapiens
brenda
Williams, V.P.; Helmer, G.R.; Fried, C.
Human galactose-1-phosphate uridylyltransferase: purification and comparison of the red blood cell and placental enzymes
Arch. Biochem. Biophys.
216
503-511
1982
Homo sapiens
brenda
Williams, V.P.
Purification and some properties of galactose 1-phosphate uridylyltransferase from human red cells
Arch. Biochem. Biophys.
191
182-191
1978
Homo sapiens
brenda
Kelly, S.; Sweeney, P.; Schedlbauer, L.
Galactose-l-phosphate uridyl transferase activity in red cells of various animal species
Experientia
37
550-553
1981
Bos taurus, Capra hircus, Cavia porcellus, Cavia porcellus Hartley, Chlorocebus aethiops, Equus caballus, Homo sapiens, Oryctolagus cuniculus, Ovis aries, Rattus norvegicus
brenda
Ellis, G.; Goldberg, D.M.
Galactose-1-phosphate uridylytransferase. UDPglucose:alpha-D-galactose-1-phosphate uridylyltransferase, EC 2.7.7.12
Methods Enzym. Anal. , 3rd. Ed. (Bergmeyer, H. U. , ed. )
3
560-571
1983
Bos taurus, Homo sapiens
-
brenda
Banroques, J.; Gregori, C.; Schapira, F.
Purification and characterization of human erythrocyte uridylyl transferase
Biochim. Biophys. Acta
657
374-382
1981
Homo sapiens
brenda
Frey, P.A.; Wong, L.J.; Sheu, K.F.; Yang, S.L.
Galactose-1-phosphate uridylyltransferase: detection, isolation, and characterization of the uridylyl enzyme
Methods Enzymol.
87
20-36
1982
Saccharomyces cerevisiae, Escherichia coli, Homo sapiens
brenda
Daude, N.; Lestage, J.; Reichardt, J.K.; Petry, K.G.
Expression of galactose-1-phosphate uridyltransferase in the anterior pituitary of rat during the estrous cycle
Neuroendocrinology
64
42-48
1996
Homo sapiens, Rattus norvegicus
brenda
Podskarbi, T.; Kohlmetz, T.; Gathof, B.S.; Kleinlein, B.; Bieger, W.P.; Gresser, U.; Shin, Y.S.
Molecular characterization of Duarte-1 and Duarte-2 variants of galactose-1-phosphate uridyltransferase
J. Inherit. Metab. Dis.
19
638-644
1996
Homo sapiens
brenda
Wells, L.; Fridovich-Keil, J.L.
Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia
J. Inherit. Metab. Dis.
20
633-642
1997
Homo sapiens
brenda
Lai, K.; Langley, S.D.; Dembure, P.P.; Hjelm, L.N.; Elsas, L.J.2nd.
Duarte allele impairs biostability of galactose-1-phosphate uridyltransferase in human lymphoblasts
Hum. Mutat.
11
28-38
1998
Homo sapiens
brenda
Lai, K.; Willis, A.C.; Elsas, L.J.
The biochemical role of glutamine 188 in human galactose-1-phosphate uridyltransferase
J. Biol. Chem.
274
6559-6566
1999
Escherichia coli (P09148), Homo sapiens
brenda
Davit-Spraul, A.; Pourci, M.L.; Ng, K.H.; Soni, T.; Lemonnier, A.
Regulatory effects of galactose on galactose-1-phosphate uridyltransferase activity on human hepatoblastoma HepG2 cells
FEBS Lett.
354
232-236
1994
Homo sapiens
brenda
Shin, Y.S.; Zschocke, J.; Das, A.M.; Podskarbi, T.
Molecular and biochemical basis for variants and deficiency forms of galactose-1-phosphate uridyltransferase
J. Inherit. Metab. Dis.
22
327-329
1999
Homo sapiens
brenda
Quimby, B.B.; Wells, L.; Wilkinson, K.D.; Fridovich-Keil, J.L.
Functional requirements of the active site position 185 in the human enzyme galactose-1-phosphate uridylyltransferase
J. Biol. Chem.
271
26835-26842
1996
Escherichia coli, Homo sapiens
brenda
Elsevier, J.P.; Wells, L.; Quimby, B.B.; Fridovich-Keil, J.L.
Heterodimer formation and activity in the human enzyme galactose-1-phosphate uridylyltransferase
Proc. Natl. Acad. Sci. USA
93
7166-7171
1996
Homo sapiens
brenda
Crews, C.; Wilkinson, K.D.; Wells, L.; Perkins, C.; Fridovich-Keil, J.L.
Functional consequence of substitutions at residue 171 in human galactose-1-phosphate uridylyltransferase
J. Biol. Chem.
275
22847-22853
2000
Homo sapiens
brenda
Riehman, K.; Crews, C.; Fridovich-Keil, J.L.
Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase
J. Biol. Chem.
276
10634-10640
2001
Homo sapiens
brenda
Christacos, N.C.; Fridovich-Keil, J.L.
Impact of patient mutations on heterodimer formation and function in human galactose-1-P uridylyltransferase
Mol. Genet. Metab.
76
319-326
2002
Homo sapiens
brenda
Geeganage, S.; Frey, P.A.
Galactose-1-phosphate uridylyltransferase: kinetics of formation and reaction of uridylyl-enzyme intermediate in wild-type and specifically mutated uridylyltransferases
Methods Enzymol.
354
134-148
2002
Escherichia coli, Homo sapiens
brenda
Coffee, B.; Hjelm, L.N.; DeLorenzo, A.; Courtney, E.M.; Yu, C.; Muralidharan, K.
Characterization of an unusual deletion of the galactose-1-phosphate uridyl transferase (GALT) gene
Genet. Med.
8
635-640
2006
Homo sapiens
brenda
Karas-Kuzelicki, N.; Pfeifer, V.; Lukac-Bajalo, J.
Synergistic effect of high lactase activity genotype and galactose-1-phosphate uridyl transferase (GALT) mutations on idiopathic presenile cataract formation
Clin. Biochem.
41
869-874
2008
Homo sapiens (P07902)
brenda
Prodan-Zitnik, I.; Karas-Kuzelicki, N.; Lukac-Bajalo, J.
Positive correlation between galactose-1-phosphate uridyltransferase (GALT) and UDP-galactose-4-epimerase (GALE) activities
Clin. Biochem.
42
1561-1564
2009
Homo sapiens
brenda
Carney, A.E.; Sanders, R.D.; Garza, K.R.; McGaha, L.A.; Bean, L.J.; Coffee, B.W.; Thomas, J.W.; Cutler, D.J.; Kurtkaya, N.L.; Fridovich-Keil, J.L.
Origins, distribution and expression of the Duarte-2 (D2) allele of galactose-1-phosphate uridylyltransferase
Hum. Mol. Genet.
18
1624-1632
2009
Homo sapiens (P07902)
brenda
Lindhout, M.; Rubio-Gozalbo, M.E.; Bakker, J.A.; Bierau, J.
Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography
Clin. Chim. Acta
411
980-983
2010
Homo sapiens
brenda
McCorvie, T.J.; Timson, D.J.
The structural and molecular biology of type I galactosemia: enzymology of galactose 1-phosphate uridylyltransferase
IUBMB Life
63
694-700
2011
Escherichia coli, Homo sapiens
brenda
McCorvie, T.J.; Gleason, T.J.; Fridovich-Keil, J.L.; Timson, D.J.
Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia
Biochim. Biophys. Acta
1832
1279-1293
2013
Homo sapiens (P07902), Homo sapiens
brenda
Choi, R.; Jo, K.I.; Ko, D.H.; Lee, D.H.; Song, J.; Jin, D.K.; Ki, C.S.; Lee, S.Y.; Kim, J.W.; Lee, Y.W.; Park, H.D.
Novel GALT variations and mutation spectrum in the Korean population with decreased galactose-1-phosphate uridyltransferase activity
BMC Med. Genet.
15
94
2014
Homo sapiens (P07902), Homo sapiens
brenda
McCorvie, T.J.; Kopec, J.; Pey, A.L.; Fitzpatrick, F.; Patel, D.; Chalk, R.; Shrestha, L.; Yue, W.W.
Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase
Hum. Mol. Genet.
25
2234-2244
2016
Homo sapiens (P07902)
brenda
Papachristoforou, R.; Petrou, P.P.; Sawyer, H.; Williams, M.; Drousiotou, A.
A novel large deletion encompassing the whole of the galactose-1-phosphate uridyltransferase (GALT) gene and extending into the adjacent interleukin 11 receptor alpha (IL11RA) gene causes classic galactosemia associated with additional phenotypic abnormalities
JIMD Rep.
12
91-98
2014
Homo sapiens (P07902), Homo sapiens
brenda
Tran, T.T.; Liu, Y.; Zwick, M.E.; Ramachandran, D.; Cutler, D.J.; Huang, X.; Berry, G.T.; Fridovich-Keil, J.L.
A de novo variant in galactose-1-P uridylyltransferase (GALT) leading to classic galactosemia
JIMD Rep.
19
1-6
2015
Homo sapiens (P07902), Homo sapiens
brenda
Janes, V.; Grabany, S.; Delbrouck, J.; Vincent, S.P.; Gottschalk, J.; Elling, L.; Hanisch, F.G.
Fluorinated galactoses inhibit galactose-1-phosphate uridyltransferase and metabolically induce galactosemia-like phenotypes in HEK-293 cells
Cells
9
607
2020
Homo sapiens (P07902)
brenda
Kumar S, U.; Kumar D, T.; R, S.; Doss C, G.P.; Zayed, H.
An extensive computational approach to analyze and characterize the functional mutations in the galactose-1-phosphate uridyl transferase (GALT) protein responsible for classical galactosemia
Comput. Biol. Med.
117
103583
2020
Homo sapiens (P07902)
brenda
McCorvie, T.J.; Kopec, J.; Pey, A.L.; Fitzpatrick, F.; Patel, D.; Chalk, R.; Shrestha, L.; Yue, W.W.
Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase
Hum. Mol. Genet.
25
2234-2244
2016
Homo sapiens (P07902)
brenda
De Lucca, M.; Casique, L.; Cornejo, V.
Alterations of galactose metabolism caused by deficit of galactose-1-phosphate uridylyltransferase activity An overview of galactosemia type I
Molecular Nutrition: Carbohydrates (ed. Patel V.B.)
2019
369-395
2019
Homo sapiens (P07902)
-
brenda